About Human Sphingosine-1-Phosphate Receptor 5 (S1PR5/EDG8) Stable Cell Line

Sphingosine-1-Phosphate Receptor 5 (S1PR5), also known as Endothelial Differentiation Gene 8 (EDG8), is a Class A G protein-coupled receptor (GPCR) that binds the bioactive lipid mediator sphingosine-1-phosphate (S1P). S1PR5 is one of five members of the sphingosine-1-phosphate receptor family (S1PR1–S1PR5), which collectively regulate immune cell trafficking, nervous system function, vascular biology, and tissue homeostasis. Upon activation by S1P, S1PR5 primarily couples to Gi and G12/13 proteins, leading to modulation of intracellular signaling pathways involved in cell migration, cytoskeletal organization, cell survival, and differentiation.

S1PR5 exhibits a distinct expression profile compared to other S1P receptors and is highly expressed in oligodendrocytes within the central nervous system, natural killer (NK) cells, and selected immune cell populations. In the nervous system, S1PR5 contributes to oligodendrocyte maturation, survival, and myelin maintenance, making it an important regulator of white matter integrity. In the immune system, S1PR5 controls NK cell trafficking and immune surveillance. Dysregulation of S1PR5 signaling has been implicated in multiple sclerosis (MS), neurodegenerative diseases, neuroinflammation, autoimmune disorders, and cancer. Consequently, S1PR5 has emerged as an important therapeutic target in neurology, immunology, and inflammatory disease research.

eEnzyme's Human S1PR5 Stable Cell Line provides a reliable and reproducible cellular platform for investigating S1PR5-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of sphingosine-1-phosphate analogs, agonists, antagonists, and novel receptor modulators through calcium mobilization assays, reporter gene assays, cAMP assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, ligand profiling, potency determination, lead optimization, and high-throughput screening applications supporting neuroscience, immunology, and neuroinflammatory disease drug discovery programs.

Applications of the S1PR5 Stable Cell Line

• S1PR5 receptor pharmacology studies
• Sphingosine-1-phosphate signaling investigations
• Agonist and antagonist screening
• Multiple sclerosis and neuroinflammation research
• Oligodendrocyte biology and myelination studies
• Natural killer (NK) cell trafficking investigations
• Calcium mobilization and GPCR functional assays
• High-throughput screening applications

Biological Significance of S1PR5

S1PR5 is a critical regulator of sphingolipid signaling within both the immune system and the central nervous system. In oligodendrocytes, activation of S1PR5 promotes cell survival, differentiation, and maintenance of myelin sheaths, processes essential for normal neuronal function and signal transmission. In the immune system, S1PR5 regulates the migration and circulation of NK cells, contributing to immune surveillance and host defense. Therapeutic modulation of S1P receptors, including S1PR5, has demonstrated clinical value in the treatment of multiple sclerosis and other neuroinflammatory diseases. Emerging evidence also suggests that S1PR5 may influence neurodegeneration, tissue repair, and tumor biology. Because of its unique roles in myelin biology, immune regulation, and neurological health, S1PR5 remains an important target for translational research and GPCR-focused drug discovery. The S1PR5 Stable Cell Line provides a valuable tool for studying sphingosine-1-phosphate receptor biology and advancing the development of next-generation therapeutics targeting neurological, autoimmune, and inflammatory disorders.